Laura D'Erasmo | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Differential effects of bariatric surgery on plasma levels of ANGPTL3 and ANGPTL4	NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES	2022
Efficacy and safety of lomitapide in homozygous familial hypercholesterolaemia: the pan-European retrospective observational study	EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY	2022
The role of lipid metabolism in shaping the expansion and the function of regulatory T cells	CLINICAL AND EXPERIMENTAL IMMUNOLOGY	2022
New and Emerging Therapies for Dyslipidemia	ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA	2022
Efficacy and safety of lomitapide in familial chylomicronaemia syndrome	ATHEROSCLEROSIS	2022
Recent Apolipoprotein CIII trials	CURRENT OPINION IN LIPIDOLOGY	2022
The interplay between angiopoietin-like proteins and adipose tissue: Another piece of the relationship between adiposopathy and cardiometabolic diseases?	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES	2021
Elevated Serum Concentrations of Remnant Cholesterol Associate with Increased Carotid Intima-Media Thickness in Children and Adolescents	JOURNAL OF PEDIATRICS	2021
HDL-Mediated Cholesterol Efflux and Plasma Loading Capacities Are Altered in Subjects with Metabolically- but Not Genetically Driven Non-Alcoholic Fatty Liver Disease (NAFLD)	BIOMEDICINES	2021
Proprotein convertase subtilisin kexin type 9 inhibitors reduce platelet activation modulating ox-LDL pathways	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES	2021
Refinement of pathogenicity classification of variants associated with familial hypercholesterolemia: Implications for clinical diagnosis	JOURNAL OF CLINICAL LIPIDOLOGY	2021
New Frontiers in the Treatment of Homozygous Familial Hypercholesterolemia	HEART FAILURE CLINICS	2021
Long-term efficacy of lipoprotein apheresis and lomitapide in the treatment of homozygous familial hypercholesterolemia (HoFH): a cross-national retrospective survey	ORPHANET JOURNAL OF RARE DISEASES	2021
Rare Treatments for Rare Dyslipidemias: New Perspectives in the Treatment of Homozygous Familial Hypercholesterolemia (HoFH) and Familial Chylomicronemia Syndrome (FCS)	CURRENT ATHEROSCLEROSIS REPORTS	2021
Clinical implications of monogenic versus polygenic hypercholesterolemia: Long-term response to treatment, coronary atherosclerosis burden, and cardiovascular events	JOURNAL OF THE AMERICAN HEART ASSOCIATION. CARDIOVASCULAR AND CEREBROVASCULAR DISEASE	2021
Lipid-lowering therapy in patients with coronary heart disease and prior stroke: Mission impossible?	JOURNAL OF CLINICAL MEDICINE	2021
The role of lipid metabolism in shaping the expansion and the function of regulatory T cells	CLINICAL AND EXPERIMENTAL IMMUNOLOGY	2021
EFFICACY AND SAFETY OF LOMITAPIDE IN HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA: THE PAN-EUROPEAN RETROSPECTIVE OBSERVATIONAL STUDY	EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY	2021
Elevated Serum Concentrations of Remnant Cholesterol Associate with Increased Carotid Intima-Media Thickness in Children and Adolescents.	THE JOURNAL OF PEDIATRICS	2021
Clinical Implications of Monogenic Versus Polygenic Hypercholesterolemia: Long-Term Response to Treatment, Coronary Atherosclerosis Burden, and Cardiovascular Events.	JOURNAL OF THE AMERICAN HEART ASSOCIATION. CARDIOVASCULAR AND CEREBROVASCULAR DISEASE	2021

Progetti di Ricerca

Studio multicentrico osservazionale di valutazione dell'efficacia della terapia con lomitapide nel migliorare il profilo lipidico e ridurre l'incidenza di eventi cardiovascolari in pazienti affetti da ipercolesterolemia familiare omozigote: analisi ...